These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33331921)

  • 1. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
    Demir S; Li J; Magder LS; Petri M
    Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
    Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
    Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
    Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
    Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
    Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.
    Petri M
    Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
    Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Kitani T; Iwatani Y; Kanakura Y
    Br J Haematol; 2001 Sep; 114(3):647-54. PubMed ID: 11552993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
    Akhter E; Shums Z; Norman GL; Binder W; Fang H; Petri M
    J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.